Literature DB >> 10469597

Mutator phenotypes of common polymorphisms and missense mutations in MSH2.

K Drotschmann1, A B Clark, T A Kunkel.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is associated with germline mutations in the DNA mismatch repair gene hMSH2 [1], the human homologue of the Escherichia coli MutS gene. These are mostly nonsense, frameshift or deletion mutations that result in loss of intact protein and complete inactivation of DNA mismatch repair. However, cancer is also associated with hMSH2 missense mutations that are merely inferred to be deleterious because they result in non-conservative substitutions of amino acids that are highly conserved among MutS family proteins. Moreover, sequence polymorphisms exist in hMSH2 that also change conserved amino acids but whose functional consequences and relationship to cancer are uncertain. Here, we show that yeast strains harboring putative equivalents of three hMSH2 polymorphisms have elevated mutation rates. Mutator effects were also observed for yeast equivalents of hMSH2 missense mutations found in HNPCC families and in an early onset colon tumor. Several distinct phenotypes were observed, indicating that these missense mutations have differential effects on MSH2 function(s). The results suggest that cancer may be associated with even partial loss of hMSH2 function and they are consistent with the hypothesis that polymorphisms in hMSH2 might predispose humans to disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469597     DOI: 10.1016/s0960-9822(99)80396-0

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  22 in total

1.  Isolation and characterization of point mutations in mismatch repair genes that destabilize microsatellites in yeast.

Authors:  E A Sia; M Dominska; L Stefanovic; T D Petes
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding.

Authors:  Jennifer L Cyr; Christopher D Heinen
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

3.  The cellular, developmental and population-genetic determinants of mutation-rate evolution.

Authors:  Michael Lynch
Journal:  Genetics       Date:  2008-08-30       Impact factor: 4.562

4.  Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions.

Authors:  Sandra L Martinez; Richard D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

5.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

6.  Distinct requirements within the Msh3 nucleotide binding pocket for mismatch and double-strand break repair.

Authors:  Charanya Kumar; Gregory M Williams; Brett Havens; Michelle K Dinicola; Jennifer A Surtees
Journal:  J Mol Biol       Date:  2013-02-28       Impact factor: 5.469

Review 7.  Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.

Authors:  Christopher D Heinen
Journal:  Mutat Res       Date:  2009-09-17       Impact factor: 2.433

8.  Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.

Authors:  Aaron R Ellison; Joan Lofing; Grant A Bitter
Journal:  Nucleic Acids Res       Date:  2004-10-08       Impact factor: 16.971

9.  Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.

Authors:  Alison E Gammie; Naz Erdeniz; Julia Beaver; Barbara Devlin; Afshan Nanji; Mark D Rose
Journal:  Genetics       Date:  2007-08-24       Impact factor: 4.562

10.  Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.

Authors:  Matjaz Vogelsang; Aleksandra Comino; Neja Zupanec; Petra Hudler; Radovan Komel
Journal:  BMC Cancer       Date:  2009-10-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.